Print Page   |   Contact Us   |   Sign In   |   Join
Fostering Innovation Act
Share |
The Fostering Innovation Act of 2013 (H. R. 2629) would direct the Securities and Exchange Commission (SEC) to redefine "accelerated filer" with respect to issuers of securities required to meet accelerated deadlines for filing their Form 10-Q quarterly reports. Also, it would require the SEC to include among accelerated filers any issuers of securities that have: (1) annual revenues in excess of $100 million, and (2) an aggregated worldwide market value between $250 million and $700 million of the voting and non-voting common equity held by non-affiliates.
In short, this bill would amend the filing status classifications in SEC Rule 12b-2 would reduce the regulatory burden for emerging bioscience companies, and allow them to spend valuable innovation capital on R&D.
MichBio supports enactment of H.R. 2629 to institute a commonsense regulatory burden for small companies and stop diversion of valuable capital from science to compliance.

Related Resources

Deconstructing the Fostering Innovation Act
BIO Praises Fostering Innovation Act
Fostering Innovation Act (H.R. 2629) (pdf)

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by®  ::  Legal